New blood test could help doctors predict which sepsis patients are most at risk
NCT ID NCT06654895
Summary
This study aims to validate a new blood test that measures a protein called IL-6. The goal is to see if a specific level of this protein can accurately predict which patients with severe sepsis or septic shock are most likely to die within 28 days. The study will enroll 700 adult patients who are admitted to the ICU with these conditions. Researchers will collect blood samples and track patient outcomes to see how well the test works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS, SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
Intermountain Health
RECRUITINGSalt Lake City, Utah, 84111, United States
Contact
-
University of Florida College of Medicine
RECRUITINGGainesville, Florida, 32610, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wake Forest School of Medicine
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.